|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01187 COFOE MEDICAL
Nominal 
31.560 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Turnover | 2,071,848 | 38.514% | 3,387,499 | 2,982,931 | 2,853,695 |
| Cost of Sales | (940,722) | 25.767% | (1,635,894) | (1,474,227) | (1,681,144) |
| Gross Profit | 1,131,126 | 51.265% | 1,751,605 | 1,508,704 | 1,172,551 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 18,839 | 92.470% | 48,474 | 2,543 | (3,393) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (6,228) | -- | 779 | (3,498) | (130) | |
| Profit / (Loss) before Taxation | 244,070 | 22.243% | 425,843 | 371,999 | 285,708 | |
| Taxation | (40,871) | 23.791% | (55,527) | (59,655) | (32,837) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (935) | -- | 1,292 | (593) | 1,409 | |
| Others | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 202,264 | 20.835% | 371,608 | 311,751 | 254,280 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (4,470) | -8.626% | (10,363) | (24,456) | (20,802) |
| Depreciation & Amortisation | 103,237 | 10.305% | 208,033 | 181,246 | 158,821 |
| Directors' Emoluments | -- | -- | 7,602 | 6,004 | 3,121 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | |
| EPS (cts) | 95.000 | 15.854% | 183.000 | 153.000 | 124.000 |
| DPS (cts) | 60.000 | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | 63.158% | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 3.419 | 3.259 | 1.923 |
| NBV per share ($) | 24.166 | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 10/09/2026 08:46 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 202,264 |
| %Change | 20.835% |
| EPS / (LPS) | RMB 0.950 |
| NBV Per Share (¥) | RMB 24.166 |